🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Collection and conservation of human biological material from fertile subje...
Status
Unknown
Location
IRCCS Ospedale San Raffaele
Start Date
2016-06-16
Trial ID
NCT06189677
Treatments Being Tested
In this exploratory adaptive clinical trial the investigators will examine ...
Status
Completed
Location
Radboudumc
Start Date
2017-12-21
Trial ID
NCT03274609
Treatments Being Tested
Carboplatin kills cancer cells mainly through induction of DNA damage (drug...
Status
Terminated
Location
University of California Los Angeles
Start Date
2010-12
Trial ID
NCT01261299
Treatments Being Tested
Investigation of the mechanisms of persistent SARS-CoV-2 associated olfacto...
Status
Recruiting
Location
Cliniques Universitaires Saint-Luc
Start Date
2024-01-24
Trial ID
NCT06482138
Treatments Being Tested
RATIONALE: Prospective trials using hemi-ablation with high intensity focus...
Status
Recruiting
Location
University College London
Start Date
2011-06-29
Trial ID
NCT01194648
This is an observational, longitudinal, prospective study for sample collec...
Status
Active Not Recruiting
Location
Institute of Human Virology, University of Maryland School of Medicine
Start Date
2014-12
Trial ID
NCT02995252
This is an ancillary laboratory study to collect and bank blood and tissue ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07550049
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
This phase III trial compares the effect of sentinel lymph node mapping to ...
Status
Recruiting
Location
George Washington University Medical Center
Start Date
2022-12-07
Trial ID
NCT05646316
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested